Antibe Therapeutics Inc(Pre-Merger) ATBPF

Question on interview

[Doccole]

Dan reported that Antibe never saw the elevated liver enzymes in the animal studies and it wasn't until after it was discovered.

how does this new formation and new tests in animal studies rule out or support a reduced potency and lower enzymes?

[StockingUp21]

And in October these tests are not done. "We can" not "we have" we can capture the necessary data via a set of lower cost, de-risking animal studies    

[MrMugsy]

First - the acute trial is only 5 days (as per Dan). 2nd - dosing will be 2-4 fold less than we had. Liver enzyme is not an issue for acute. Also - 5 days is self-limiting and after 5 days, it's self-repairing. Wins all around. Risk has moved elsewhere. -------------------- Different story on the chronic side with 3 potential ways to market (as I see it).

[Doccole]

I look forward to being back in the trials.  Nice to see the zacks report.  Nice to see some inside buying.  More positive than usual.  let's pray this drug change is the one that makes the difference!

[MrMugsy]

Hahaha - wouldn't rely on prayer here. Focus on a deep understanding and an ability to pivot where/when needed. This is where the cash comes in useful ... to solve problems. I'm going to maintain that we needed the chronic problem to rear it's head ... so we could figure it out. Best we found it where we did rather than during P2 or P3-chronic. The AME was a perfect place - unfortunate